Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Pharmacogenomics J. 2011 Sep 13;13(1):44–51. doi: 10.1038/tpj.2011.40

Table 6.

Relationship between CYP4A11 T8590C and components of the metabolic syndrome in the Vanderbilt BioVU Cohort

Obesity Hypertriglyceridemia High Blood Pressure Impaired Fasting Glucose Low HDL-C Metabolic Syndrome
Unadjusted P
All (N=708) 0.31 0.54 0.83 0.28 0.14 0.92
Female (N=360) 0.32 0.75 0.93 0.12 0.03 0.53
Male (N=348) 0.67 0.73 0.58 0.82 0.97 0.37
Adjusted P*
All (708) 0.56 0.91 0.25 0.15 0.83
Female (N=360) 0.91 0.90 0.06 0.04 0.76
Male (N=348) 0.61 0.69 0.96 0.96 0.48
*

Adjusted for age, age2 and body mass index. Subjects taking estrogen were excluded. HDL-C indicates high density lipid cholesterol